Ziapin2 effectively restores retinal function in preclinical models of retinitis pigmentosa and macular degeneration

A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and IRCCS Ospedale Policlinico San Martino has demonstrated the effectiveness of the Ziapin2 molecule as a promising new instrument in countering the effects of retinitis pigmentosa and age-related macular degeneration, conditions that lead to the progressive deterioration of the photoreceptors in the retina, causing progressive blindness.